Location History:
- Kyunggi-Do, KR (1997)
- Sungnam-si, KR (2006)
Company Filing History:
Years Active: 1997-2006
Title: Yeo Wook Koh: Innovator in Biotechnology
Introduction
Yeo Wook Koh is a prominent inventor based in Sungnam-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of novel human thrombopoietin derivatives. His work has the potential to impact treatments for various medical conditions.
Latest Patents
Yeo Wook Koh holds 2 patents. His latest patents include a human thrombopoietin comprising glycosylation sites at residues 157 and 164. This invention relates to novel human thrombopoietin (hTPO) derivatives and the process of their preparation. Specifically, sugar chains are introduced into native hTPO by substituting amino acids at specific positions, resulting in hTPO derivatives with enhanced activities that promote platelet production in vivo. These novel hTPO derivatives may be beneficial for treating thrombocytopenia associated with anticancer therapy or bone marrow transplantation. Another patent involves the gene coding for human epidermal growth factor and the process for its preparation.
Career Highlights
Yeo Wook Koh is currently employed at Daewoong Pharmaceutical Co., Ltd., where he continues to innovate in the field of biotechnology. His work is characterized by a commitment to advancing medical treatments through scientific research and development.
Collaborations
He collaborates with notable colleagues, including Joo Young Chung and Sang Kyu Park, contributing to a dynamic research environment that fosters innovation.
Conclusion
Yeo Wook Koh's contributions to biotechnology, particularly through his patents, highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also holds promise for improving patient care.